Oral formulations of ubidecarenone in form of capsules

Details Oral formulations of ubidecarenone in form of capsules Oral formulations of ubidecarenone in form of capsules

1994-03-30

1995-08-22

Marquis, Melvyn I.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424455, 424 941, A61K 948

Patent

active

054438420

ABSTRACT:
Pharmaceuticals formulations are described, in form of capsules ad oral use, containing as the active ingredient ubidecarenone, characterized in that the active ingredient is dispersed in a mixture of isopropyl myristate or isopropyl palmitate with polyethoxylated, hydrogenated or non hydrogenated, castor oils.

REFERENCES:
patent: 4869900 (1989-09-01), Pozzi et al.
patent: 4944949 (1990-07-01), Story et al.
patent: 5037698 (1991-08-01), Brunel
patent: 5110602 (1992-05-01), Kim et al.
patent: 5139740 (1992-08-01), Uesugi et al.
patent: 5140021 (1992-08-01), Maxson et al.
patent: 5153001 (1992-10-01), Ismail
patent: 5200192 (1993-04-01), Wimmer
patent: 5206219 (1993-04-01), Desai

Affiliated with

Also associated with

Rating

Oral formulations of ubidecarenone in form of capsules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral formulations of ubidecarenone in form of capsules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral formulations of ubidecarenone in form of capsules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2140403